SK285200B6 - Použitie flunarizínu na zníženie očnej hypertenzie - Google Patents
Použitie flunarizínu na zníženie očnej hypertenzie Download PDFInfo
- Publication number
- SK285200B6 SK285200B6 SK499-2000A SK4992000A SK285200B6 SK 285200 B6 SK285200 B6 SK 285200B6 SK 4992000 A SK4992000 A SK 4992000A SK 285200 B6 SK285200 B6 SK 285200B6
- Authority
- SK
- Slovakia
- Prior art keywords
- flunarizine
- ophthalmic drug
- eye
- intraocular pressure
- ophthalmic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97RM000613A IT1295423B1 (it) | 1997-10-10 | 1997-10-10 | Uso della flunarizina nella terapia topica del glaucoma |
| PCT/IT1998/000266 WO1999018963A1 (en) | 1997-10-10 | 1998-10-06 | Use of flunarizine for the topical treatment of glaucoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK4992000A3 SK4992000A3 (en) | 2000-12-11 |
| SK285200B6 true SK285200B6 (sk) | 2006-08-03 |
Family
ID=11405290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK499-2000A SK285200B6 (sk) | 1997-10-10 | 1998-10-06 | Použitie flunarizínu na zníženie očnej hypertenzie |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6380198B1 (de) |
| EP (1) | EP1021184B1 (de) |
| JP (1) | JP4475802B2 (de) |
| AT (1) | ATE289198T1 (de) |
| AU (1) | AU734137B2 (de) |
| BR (1) | BR9813855A (de) |
| CA (1) | CA2306371C (de) |
| CZ (1) | CZ294314B6 (de) |
| DE (1) | DE69829062T2 (de) |
| ES (1) | ES2237852T3 (de) |
| HU (1) | HU227940B1 (de) |
| IT (1) | IT1295423B1 (de) |
| PL (1) | PL192217B1 (de) |
| PT (1) | PT1021184E (de) |
| SK (1) | SK285200B6 (de) |
| WO (1) | WO1999018963A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1252895A4 (de) * | 2000-01-31 | 2003-04-16 | Santen Pharmaceutical Co Ltd | Heilmittel für ophthalmologische zustände |
| JP2005536516A (ja) * | 2002-07-23 | 2005-12-02 | ノバルティス アクチエンゲゼルシャフト | 薬剤、軟膏基剤および可溶化剤／分散剤を含む、眼科用軟膏組成物 |
| JP5319920B2 (ja) * | 2004-09-10 | 2013-10-16 | ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー | ナトリウムおよび／またはカルシウムチャンネル選択的調節因子として活性のある医薬の製造のための（ハロベンジルオキシ）ベンジルアミノ−プロパンアミドの使用 |
| SI1963280T1 (sl) * | 2005-12-22 | 2016-02-29 | Newron Pharmaceuticals S.P.A. | 2-feniletilamino derivati kot modulatorji kalcijevih in/ali natrijevih kanalčkov |
| US20070149593A1 (en) * | 2005-12-23 | 2007-06-28 | Alcon, Inc. | PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
| PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
| TWI544922B (zh) | 2011-05-19 | 2016-08-11 | 愛爾康研究有限公司 | 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物 |
| EP2723710B1 (de) | 2011-06-27 | 2016-08-10 | Newron Pharmaceuticals S.p.A. | Fluorierte arylalkylaminocarboxamidderivate |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2131101A1 (en) * | 1992-05-13 | 1993-11-25 | Louis Desantis Jr. | Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents |
-
1997
- 1997-10-10 IT IT97RM000613A patent/IT1295423B1/it active IP Right Grant
-
1998
- 1998-10-06 DE DE69829062T patent/DE69829062T2/de not_active Expired - Lifetime
- 1998-10-06 EP EP98950292A patent/EP1021184B1/de not_active Expired - Lifetime
- 1998-10-06 US US09/509,912 patent/US6380198B1/en not_active Expired - Lifetime
- 1998-10-06 AU AU96433/98A patent/AU734137B2/en not_active Ceased
- 1998-10-06 CA CA002306371A patent/CA2306371C/en not_active Expired - Fee Related
- 1998-10-06 SK SK499-2000A patent/SK285200B6/sk not_active IP Right Cessation
- 1998-10-06 BR BR9813855-3A patent/BR9813855A/pt not_active Application Discontinuation
- 1998-10-06 PL PL339453A patent/PL192217B1/pl unknown
- 1998-10-06 CZ CZ20001213A patent/CZ294314B6/cs not_active IP Right Cessation
- 1998-10-06 PT PT98950292T patent/PT1021184E/pt unknown
- 1998-10-06 HU HU0003803A patent/HU227940B1/hu not_active IP Right Cessation
- 1998-10-06 ES ES98950292T patent/ES2237852T3/es not_active Expired - Lifetime
- 1998-10-06 JP JP2000515598A patent/JP4475802B2/ja not_active Expired - Fee Related
- 1998-10-06 WO PCT/IT1998/000266 patent/WO1999018963A1/en active IP Right Grant
- 1998-10-06 AT AT98950292T patent/ATE289198T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| ITRM970613A1 (it) | 1999-04-10 |
| HUP0003803A3 (en) | 2001-12-28 |
| EP1021184B1 (de) | 2005-02-16 |
| SK4992000A3 (en) | 2000-12-11 |
| JP4475802B2 (ja) | 2010-06-09 |
| WO1999018963A1 (en) | 1999-04-22 |
| DE69829062T2 (de) | 2006-02-09 |
| CZ20001213A3 (cs) | 2000-07-12 |
| ES2237852T3 (es) | 2005-08-01 |
| AU9643398A (en) | 1999-05-03 |
| AU734137B2 (en) | 2001-06-07 |
| CA2306371A1 (en) | 1999-04-22 |
| DE69829062D1 (de) | 2005-03-24 |
| PT1021184E (pt) | 2005-06-30 |
| US6380198B1 (en) | 2002-04-30 |
| BR9813855A (pt) | 2000-09-19 |
| CZ294314B6 (cs) | 2004-11-10 |
| PL339453A1 (en) | 2000-12-18 |
| HUP0003803A2 (hu) | 2001-05-28 |
| PL192217B1 (pl) | 2006-09-29 |
| HU227940B1 (hu) | 2012-06-28 |
| ATE289198T1 (de) | 2005-03-15 |
| IT1295423B1 (it) | 1999-05-12 |
| EP1021184A1 (de) | 2000-07-26 |
| JP2001519394A (ja) | 2001-10-23 |
| CA2306371C (en) | 2008-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Baudouin | Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma | |
| KR20080011310A (ko) | 폴록사머 또는 메록사폴 계면활성제 및 글리콜을유효성분으로 함유하는 현탁제, 안질환 치료용 의약의제조를 위한 그의 용도 | |
| KR20080011311A (ko) | 안과 약제, 폴록사민 및 글리콜 장성―조절제를 포함하는안과 현탁제, 안질환 치료용 의약의 제조를 위한 상기조성물의 용도 | |
| CA2840734A1 (en) | Macrogol 15 hydroxystearate formulations | |
| Maślanka | A review of the pharmacology of carbonic anhydrase inhibitors for the treatment of glaucoma in dogs and cats | |
| WO1989010757A1 (en) | New ophthalmic preparation for treating glaucoma | |
| AU636685B2 (en) | Compositions of antiallergics and antihistamines and methods for their use | |
| EP1004307B1 (de) | Ophthalmische zubereitung | |
| SK285200B6 (sk) | Použitie flunarizínu na zníženie očnej hypertenzie | |
| EP1283043A1 (de) | Ophthalmische lösung | |
| US20030007971A1 (en) | Remedies for ophthalmic diseases | |
| ASHTON et al. | The effect of chlorhexidine acetate on the corneal penetration of sorbitol from an arnolol formulation in the albino rabbit | |
| EP3730137B1 (de) | Therapeutikum für glaukom mit einem fp-agonisten und timolol | |
| RU2434633C2 (ru) | Фармацевтические препаративные формы латрункулина | |
| EP0728480A1 (de) | Verwendung von Ifenprodil zur Behandlung von erhöhtem Augeninnendruck | |
| EP1252895A1 (de) | Heilmittel für ophthalmologische zustände | |
| Plummer | Part 5: Medical Therapy for Glaucoma | |
| US6248759B1 (en) | Method for treatment of light-injured retinal degeneration disease | |
| Burstein | Basic Science of Ocular | |
| US20150174122A1 (en) | Methods for treating eye disorders using opioid receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20151006 |